The first week of December marks the largest life science partnering and venture week in the UK. If you’re raising pre-seed, seed, round A or round B, or are in phase 2 or earlier development, Life Science Nation’s (LSN) RESI London, One Nucleus’ Gensis, and ELRIG/SLAS events offer far better partnering, investment, learning, and procurement opportunities compared to the health care week in late November (concurrent with the Jefferies investment banking event), for a fraction of the cost. That week tends to focus on recent IPOs and companies that are close to IPO, along with phase 3 or more advanced companies looking for partnerships. If you’re not at that stage, save your critical conference and travel budgets for an event series that’s right for you.

RESI London and Gensis are combining to offer a multi-day investment, partnering and thought leadership event for venture stage companies seeking funding and strategic alliances:

December 2nd

• Free course on fundraising, including networking, offered by LSN
• Free ELRIG / SLAS drug-discovery focused networking event
• Genesis welcome reception for Genesis and RESI registrants

December 3rd

• Genesis “Maximising Returns from Life Science Innovation” KOL & partnering event
• Genesis evening reception

December 4th

• RESI London fundraising & partnering event, featuring 200 investors & in-licensors
• RESI London evening reception

December 8-9th

• RESI London virtual partnering

During the entire week you are also welcome to attend the Genesis Fringe events for free including networking breakfasts, lunches and other events with topics similar to Building a World Class Life Science Ecosystem, Accessing US Investors and Exits, IP Strategies in Advanced Therapy Dealmaking, Top Talent Trends for Life Sciences in 2025 and Pay Transparency, R&D to Commercialization in Rare Diseases, and more.

🔗 New this year: A combi ticket option is available for RESI London + Genesis 2025, giving you access to both premier partnering events in one streamlined package.